Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMJFLK0)

Drug Name

ISIS 2920 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Cytomegalovirus IE2 region messenger RNA (CMV IE2 mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Fomivirsen sodium	DMBEP7G	Cytomegalovirus retinitis	9B72.00	Approved	[2]
ISIS 12659	DMZGKHO	Discovery agent	N.A.	Investigative	[3]
ISIS 2921	DMDZAKS	Discovery agent	N.A.	Investigative	[1]
ISIS 3246	DM56EZC	Discovery agent	N.A.	Investigative	[1]
ISIS 2919	DMVMF5X	Discovery agent	N.A.	Investigative	[1]
ISIS 2918	DMJTHXY	Discovery agent	N.A.	Investigative	[1]
ISIS 12660	DMNOPWB	Discovery agent	N.A.	Investigative	[3]
ISIS 3300	DM2TIO1	Discovery agent	N.A.	Investigative	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Cytomegalovirus IE2 region messenger RNA (CMV IE2 mRNA)	TT4SCBE	VIE2_HCMVA	Not Available	[1]

------------------------------------------------------------------------------------

References

1	US patent application no. 5,442,049, Oligonucleotides for modulating the effects of cytomegalovirus infections.
2	Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3	US patent application no. 5,767,102, Antisense composition and method for treatment of CMV infection.